/Companies

DiCE Molecules

Menlo Park, US · Founded 2013 · 1 known investors

Find your way into DiCE Molecules

437 people in our graph share verified history with the DiCE Molecules team — schools, employers, funds. One of them is your warm intro.

Timothy Wrightunlockedknows Kevin Judice · together at Calibr at Scripps Research (overlapped)
×3knows the team · via Calibr at Scripps Research
×3knows the team · via Theravance Biopharma
×5knows the team · via Texas A&M University

Founders & leadership

DiCE Molecules was founded in 2013 by Kevin Judice and Pehr Harbury.

KJKevin Judice
Kevin JudiceCo-founderKevin Judice has over 25 years of experience in biotech, including roles as founder and CEO of Achaogen, co-founder and Acting Chief Scientific Officer at Cidara Therapeutics, and an early employee at Theravance. He is currently CEO and co-founder of DiCE Molecules.
PH
Pehr HarburyCo-founder
MR
Michael RabsonExecutive
JB
John BedbrookExecutive

Board

PP
Phil PattenBoard director

Investors · 1

Reported raises · per SEC filings

Form D private placements

$161.7M disclosed across 5 rounds · 2013–2021

▶$60MraisedSep 2021 · 19 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Stephen ZacharyDirector
  • Sharon TetlowDirector
  • Jim ScopaDirector
  • Richard SchellerDirector
  • Kevin JudiceExecutive Officer, Director
  • Shaan GandhiDirector
  • Scott RobertsonExecutive Officer
  • Jake SimsonDirector
Offering amount
$60M
Amount sold
$60M
First sale
Aug 2021
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$54.3MraisedJan 2021 · 27 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kevin JudiceExecutive Officer, Director
  • Jim ScopaDirector
  • Shaan GandhiDirector
  • Jake SimsonDirector
  • Richard SchellerDirector
  • Scott RobertsonExecutive Officer
  • Stephen ZacharyDirector
  • Sharon TetlowDirector
Offering amount
$81.5M
Amount sold
$54.3M
Placement agents
SVB Leerink LLC
First sale
Dec 2020
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$40.5MraisedJul 2018 · 19 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Phillip PattenDirector
  • John BedbrookDirector
  • Pehr HarburyDirector
  • Stephen ZacharyDirector
  • Michael RubinDirector
  • Scott RobertsonExecutive Officer
  • Kevin JudiceExecutive Officer, Director
  • Richard SchellerDirector
Offering amount
$60M
Amount sold
$40.5M
Placement agents
JMP Group LLC
First sale
Jul 2018
Incorporated
Limited Liability Company, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4MraisedJun 2015 · 11 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael RabsonExecutive Officer, Promoter
  • Kevin JudiceExecutive Officer, Promoter
Offering amount
$4.5M
Amount sold
$4M
First sale
Jun 2015
Incorporated
Limited Liability Company, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.9MraisedFeb 2014 · 12 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • John BedbrookExecutive Officer, Director
  • Phil PattenDirector
  • Kevin JudiceExecutive Officer, Director
  • Pehr HarburyDirector
Offering amount
$3.5M
Amount sold
$2.9M
First sale
Dec 2013
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who founded DiCE Molecules?
DiCE Molecules was founded by Kevin Judice, Pehr Harbury in 2013.
Who are DiCE Molecules's investors?
DiCE Molecules's investors include RA Capital.
How much funding has DiCE Molecules raised?
DiCE Molecules has disclosed $161.7M raised across 5 rounds.
Where is DiCE Molecules headquartered?
DiCE Molecules is headquartered in Menlo Park, US.